PPARA and chronic kidney disease: In advanced stages of CKD, there is an increase in ChREBP, FAS, and ACC, downregulation of the peroxisome proliferator-activated receptor-alpha (PPARα)-regulated fatty acid oxidation system, and reduction of diacylglycerol acyltransferases (DGAT), resulting in HTG [71].